Quantification of 5-methyl-2'-deoxycytidine in the DNA.

  • Małgorzata Giel-Pietraszuk Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.;
  • Małgorzata Insińska-Rak Faculty of Chemistry, Adam Mickiewicz University in Poznan, Poznań, Poland.;
  • Anna Golczak Faculty of Chemistry, Adam Mickiewicz University in Poznan, Poznań, Poland.;
  • Marek Sikorski Faculty of Chemistry, Adam Mickiewicz University in Poznan, Poznań, Poland.;
  • Mirosława Barciszewska Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.;
  • Jan Barciszewski Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.;

Abstract

Methylation at position 5 of cytosine (Cyt) at the CpG sequences leading to formation of 5-methyl-cytosine (m(5)Cyt) is an important element of epigenetic regulation of gene expression. Modification of the normal methylation pattern, unique to each organism, leads to the development of pathological processes and diseases, including cancer. Therefore, quantification of the DNA methylation and analysis of changes in the methylation pattern is very important from a practical point of view and can be used for diagnostic purposes, as well as monitoring of the treatment progress. In this paper we present a new method for quantification of 5-methyl-2'deoxycytidine (m(5)C) in the DNA. The technique is based on conversion of m(5)C into fluorescent 3,N(4)-etheno-5-methyl-2'deoxycytidine (εm(5)C) and its identification by reversed-phase high-performance liquid chromatography (RP-HPLC). The assay was used to evaluate m(5)C concentration in DNA of calf thymus and peripheral blood of cows bred under different conditions. This approach can be applied for measuring of 5-methylcytosine in cellular DNA from different cells and tissues.
Published
2015-06-22
Section
Articles